[go: up one dir, main page]

IN2013MU01986A - - Google Patents

Download PDF

Info

Publication number
IN2013MU01986A
IN2013MU01986A IN1986MU2013A IN2013MU01986A IN 2013MU01986 A IN2013MU01986 A IN 2013MU01986A IN 1986MU2013 A IN1986MU2013 A IN 1986MU2013A IN 2013MU01986 A IN2013MU01986 A IN 2013MU01986A
Authority
IN
India
Prior art keywords
formulation
drug
action
delivery
nasal
Prior art date
Application number
Other languages
English (en)
Inventor
Gore Pradnya
Shetty Pushparaj
Mala D Menon Dr Mrs
Original Assignee
Mala D Menon Dr Mrs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mala D Menon Dr Mrs filed Critical Mala D Menon Dr Mrs
Priority to IN1986MU2013 priority Critical patent/IN2013MU01986A/en
Publication of IN2013MU01986A publication Critical patent/IN2013MU01986A/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN1986MU2013 2013-06-11 2013-06-11 IN2013MU01986A (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN1986MU2013 IN2013MU01986A (fr) 2013-06-11 2013-06-11

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1986MU2013 IN2013MU01986A (fr) 2013-06-11 2013-06-11

Publications (1)

Publication Number Publication Date
IN2013MU01986A true IN2013MU01986A (fr) 2015-05-29

Family

ID=54396293

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1986MU2013 IN2013MU01986A (fr) 2013-06-11 2013-06-11

Country Status (1)

Country Link
IN (1) IN2013MU01986A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023192691A3 (fr) * 2022-04-01 2024-01-25 Wake Forest University Health Sciences Procédés et formulations pour l'administration intranasale d'insuline dans le traitement d'une maladie oculaire diabétique

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023192691A3 (fr) * 2022-04-01 2024-01-25 Wake Forest University Health Sciences Procédés et formulations pour l'administration intranasale d'insuline dans le traitement d'une maladie oculaire diabétique

Similar Documents

Publication Publication Date Title
IL272423A (en) Administration, use and therapeutic applications of the CRISPR-CAS system and preparations for targeting disorders and diseases by using particulate delivery components
SG11201510286QA (en) Delivery, use and therapeutic applications of the crispr-cas systems and compositions for targeting disorders and diseases using viral components
PH12016501966B1 (en) Compounds and compositions as toll-like receptor 7 agonists
WO2014145159A3 (fr) Anticorps à charge génétiquement modifiée ou compositions de protéines de ciblage à pénétration améliorée et méthodes d'utilisation
MX2014000779A (es) Derivados de carboxamida y urea que contienen pirazol heteroaromatico sustituido como ligandos del receptor de vanilloide.
MX2017005834A (es) Polinucleotidos aad para el tratamiento de la enfermedad de parkinson.
MX2013011908A (es) Composiciones y usos terapeuticos de inhibidores de cinasa epsilon relacionados con cinasa i-kappa b (ikk) y cinasa 1 de union tank.
PH12016500862B1 (en) Autotaxin inhibitor compounds
IN2014DN09434A (fr)
PH12016502015A1 (en) Anti-factor d antibody variants and uses thereof
MX2018004755A (es) Entrega de polinucleotidos dirigidos al sistema nervioso central.
MX2023000255A (es) Formas de dosificacion de ruxolitinib de liberacion sostenida.
PH12017500401A1 (en) Therapeutic compounds as inhibitors of the orexin-1 receptor
WO2014184576A3 (fr) Administration de substances médicamenteuses
MX2016007445A (es) Inhibidores de f1f0-atpasa de trifluorometil pirazolil guanidina y usos terapeuticos de los mismos.
PH12016500863A1 (en) Tetracyclic autotaxin inhibitors
MX2013006398A (es) Inhibidores de f1f0-atpasas de tipo piridonilguanidina y usos terapeúticos.
WO2013185048A3 (fr) Inhibiteurs d' atpase de type f1f0, à base de guanidine hétérocyclique et leurs utilisations thérapeutiques
MX344590B (es) Inhibidores de f1f0-atpasas de tipo pirazolilguanidina y sus usos terapéuticos.
MY201535A (en) Therapeutic compounds
EA201691567A1 (ru) Способы лечения легких травм головного мозга
LT2774991T (lt) Vaisto įvedimo sistema, skirta naudoti neurologinių sutrikimų gydymui arba diagnostikai
MX2014000963A (es) Derivados de carboxamida y urea aromaticos biciclicos sustituidos como ligandos del receptor de vanilloide.
MX2016005614A (es) Cuerpos de inclusion para el suministro transdermico de agentes terapeuticos y cosmeticos.
IN2013MU01986A (fr)